| Hang Seng Index | 23.160 HKD | -0.780 | -3.258% | 1.30B | 30.41B | 23.947 (-3.287%) HKD as at 2025/02/27 | | |
| Hang Seng China Enterprises | 86.100 HKD | -3.260 | -3.648% | 173.36M | 15.08B | 89.976 (-4.308%) HKD as at 2025/02/26 | | |
| Hang Seng TECH Index | 5.425 HKD | -0.325 | -5.652% | 2.37B | 13.12B | 5.758 (-5.788%) HKD as at 2025/02/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 6.185 HKD | -0.780 | -11.199% | 502.93M | 3.22B | 7.175 (-13.797%) HKD as at 2025/02/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.898 HKD | +0.186 | +10.864% | 1.41B | 2.60B | 1.667 (+13.878%) HKD as at 2025/02/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.736 HKD | +0.170 | +6.625% | 344.34M | 925.79M | 2.547 (+7.437%) HKD as at 2025/02/26 | | |
| Hang Seng TECH Index | 11.640 HKD | -0.590 | -4.824% | 48.53M | 572.34M | 12.477 (-6.705%) HKD as at 2025/02/26 | | |
| Hang Seng TECH Index | 7.020 HKD | -0.420 | -5.645% | 70.53M | 506.34M | 7.542 (-6.921%) HKD as at 2025/02/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 4.938 HKD | -0.352 | -6.654% | 97.87M | 491.92M | 5.330 (-7.358%) HKD as at 2025/02/26 | | |
| Hang Seng TECH Index | 5.505 HKD | -0.335 | -5.736% | 59.14M | 330.64M | 5.911 (-6.875%) HKD as at 2025/02/26 | | |
| CSI 300 | 42.820 HKD | -1.060 | -2.416% | 4.82M | 207.53M | 43.824 (-2.292%) HKD as at 2025/02/26 | | |
| FTSE 3-Month US Dollar Eurodeposit Index | 116.800 USD | 0.000 | 0.000% | 1.15M | 134.33M | 116.803 (-0.003%) USD as at 2025/02/27 | | |
| FTSE China A50 | 12.600 HKD | -0.230 | -1.793% | 9.24M | 117.35M | 12.845 (-1.904%) HKD as at 2025/02/27 | | |
| FTSE China A50 | 13.510 HKD | -0.210 | -1.531% | 7.47M | 101.48M | 13.656 (-1.068%) HKD as at 2025/02/26 | | |
| Hang Seng China Enterprises | 10.380 HKD | -0.380 | -3.532% | 8.45M | 88.48M | 10.809 (-3.972%) HKD as at 2025/02/26 | | |
| MSCI China | 23.240 HKD | -0.840 | -3.488% | 3.56M | 84.16M | 24.274 (-4.260%) HKD as at 2025/02/26 | | |
| London Gold Fixing Price | 2,050.000 HKD | -21.000 | -1.014% | 39.78K | 81.73M | N/A | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.300 HKD | +0.314 | +6.298% | 12.90M | 68.49M | 5.031 (+5.347%) HKD as at 2025/02/26 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 9.700 HKD | -0.900 | -8.491% | 6.64M | 65.88M | 10.635 (-8.787%) HKD as at 2025/02/27 | | |
| HSI ESG Enhanced Index (net total return index) | 47.440 HKD | -1.780 | -3.616% | 913.76K | 43.27M | 49.487 (-4.135%) HKD as at 2025/02/26 | | |
| Hang Seng High Dividend Yield | 24.380 HKD | -0.540 | -2.167% | 1.42M | 34.91M | 24.990 (-2.441%) HKD as at 2025/02/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 13.130 HKD | -0.260 | -1.942% | 2.58M | 34.02M | 13.665 (-3.913%) HKD as at 2025/02/26 | | |
| CSI 300 | 40.220 CNY | -0.820 | -1.998% | 806.64K | 32.54M | 40.948 (-1.778%) CNY as at 2025/02/26 | | |
| CME Bitcoin Futures | 27.560 HKD | -2.580 | -8.560% | 1.14M | 31.92M | 29.506 (-6.596%) HKD as at 2025/02/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.192 HKD | -0.260 | -7.532% | 7.01M | 22.83M | 3.511 (-9.088%) HKD as at 2025/02/26 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.862 HKD | -0.336 | -8.004% | 5.10M | 20.07M | 4.216 (-8.403%) HKD as at 2025/02/27 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.644 HKD | -0.164 | -4.307% | 5.23M | 19.37M | 3.824 (-4.707%) HKD as at 2025/02/27 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 10.170 HKD | -0.460 | -4.327% | 1.79M | 18.33M | 10.562 (-3.708%) HKD as at 2025/02/26 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.805 HKD | +0.049 | +6.481% | 21.24M | 17.14M | 0.764 (+5.380%) HKD as at 2025/02/26 | | |
| MSCI China A 50 Connect Index (net total return index) | 5.115 HKD | -0.100 | -1.918% | 3.20M | 16.45M | 5.182 (-1.287%) HKD as at 2025/02/26 | | |